WorkSafe has released guidance for managing and removing asbestos in the workplace, the first of its kind in New Zealand. The Approved Code of Practice for the Management and Removal of Asbestos will help contribute to WorkSafe’s target of a 50% reduction in asbestos-related disease by 2040.
The package is maintained by Brian Chapman at the University of Utah. Other active and past developers include: – Wendy W. Chapman – Glenn Dayton – Danielle Mowery Introduction ———— pyConTextNLP is a partial implementation of the ConText algori…
Hurricane Matthew left behind millions of dollars of destruction along the coasts of Florida, Georgia and the Carolinas. Hundreds of thousands of people lost power to their homes, businesses and schools as powerful winds, heavy rains and widespread flo…
A grandfather who died from an asbestos-related disease recalled before his death how he was exposed to the building material during his time at a Long Melford factory. Christopher Gaw, 74, of Long Melford’s High Street, died on August 31 at West Suffolk Hospital after developing mesothelioma.
Initial results indicate for the first time a meaningful clinical benefit among high-risk multiple myeloma patients, who typically relapse within a year of ASCT. SELLAS’ lead product candidate, galinpepimut-S, was licensed from Memorial SloanKettering Cancer Center and is a late-stage innovative WT1 targeted immunotherapeutic, with the potential to treat multiple tumor types.
Targeted therapy aimed at specific genetic mutations can lead to significant improvement in progression-free survival for many cancer patients, including those with mesothelioma, a recent study shows. The research team at Intermountain Precision Genomics in St. George, Utah, found that matching tumor-related genetic mutations to drugs specific to the corresponding abnormality slows or stops many…
The post Researchers Treat Mesothelioma with Precision Medicine appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.
The Sbarro Health Research Organization , in collaboration with Temple University’s College of Science and Technology, the National Italian American Foundation , and the Giovan Giacomo Giordano Foundation will host the medical conference “Women Leaders in Advanced Cancer Research” 9 A.M on Saturday, October 15th at the Marriot Wardman Park Hotel in Washington, D.C. The conference will feature an introduction on “Women Leaders in Advanced Cancer Research” presented by SHRO’s President Antonio Giordano who is also director of Temple’s Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology.
Recently published results from a clinical trial show DNA screening may help doctors more effectively treat mesothelioma patients using chemotherapy.
Recently published results from a clinical trial show DNA screening may help doctors more effectively treat mesothelioma patients using chemotherapy.
Stacy Cattran holds her father Bill Coulbeck’s helmet in her home in Guelph, Ontario, on October 9, 2016. Her father died of mesothelioma after being exposed to asbestos while he worked.
My late husband, Sean Sasser, taught a whole generation of Americans what it’s like to be a person of color, gay and living with HIV. Back in 1994, he was a fixture in MTV’s “Real World: San Francisco” household, and his public advocacy for people living with HIV was revolutionary.
The Mesothelioma Compensation Center says, “We are now offering a US Navy Veteran, or their family members, a reality check when it comes to hiring a lawyer or law firm to assist with a mesothelioma compensation claim if they would call us at 866-714-6…
Asbestos is typically thought of as a substance that is no longer in use anymore because it is a well-known carcinogen. Asbestos is fire resistant, strong, cheap, abundant, and absorbs sound. It is no wonder it rose to popularity throughout the 20th century since it was so versatile. While asbestos is solid rock, it is
Over a dozen workers were exposed to asbestos during recent construction on Building 36 at the Veterans Affairs campus in Canandaigua, NY.
The first two-tier grading system for peritoneal mesothelioma has produced a significant subset of patients with an incredible median overall survival of nearly 12 years. That pathology-based grading system should provide patients with a more accurate prognosis, potentially helping doctors design more personalized and effective therapies. “We can tell patients now what the future holds….
The post Peritoneal Mesothelioma Grading System Improves Prognosis appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.